Investment Pitches

Pitch Summary:
Euronet has been another material performance detractor for Voss YTD. We reduced our position to harvest some tax losses following a disappointing third quarter that invalidated some pillars of our original thesis. While we previously viewed the company as a mispriced "growth-at-a-reasonable-price" story supported by a diverse portfolio with an A+ management team, recent results reveal weakness across all segments coupled with a lack of visibility into near-term growth drivers. A resumption of buybacks and an analyst day early in 2026 after reporting Q4 results are desperately needed catalysts. Our constructive view of the stock has been predicated upon the resilience of Euronet’s diversified payments model and the latent value of its growth initiatives (REN, Dandelion, Merchant Services). However, Q3 results threw some shade on this narrative. While we expected that EEFT’s segment diversity would smoothen volatility, all three segments underperformed. ePay revenue declined 5% on a constant currency basis, a material negative surprise, while the Money Transfer segment struggled with margin pressures and lackluster growth, though still handily outperforming peers such as Intermex. We anticipated rising incremental margins in the Electronic Funds Transfer (EFT) segment driven by new ATM surcharges and growth from higher margin REN. Instead, incremental margins have declined for four consecutive quarters, dropping from ~52% to ~27% on a rolling 12-month basis. Management cited idiosyncratic headwinds (e.g., a $6M impact in Mexico due to sponsor bank issues and geopolitical impacts in Egypt), but the frequency of these "one-time" events is becoming a pattern. Our anticipated segment reporting breakout of EEFT’s high-growth assets like REN, Dandelion, and Merchant Acquiring has also failed to materialize in the financial disclosures. These assets remain obscured within legacy segments, and growth has seemingly slowed. The stock has de-rated all the way from 20x+ earnings to under 7x, but this compression is now accompanied by genuine downward revisions estimates rather than just multiple contraction. The lack of near-term momentum and the looming 1% remittance tax in 2025 creates a difficult path for stock appreciation in the short term, but we think a late Q1 ’26 analyst day will be a critical catalyst and opportunity to reset the narrative and provide more disclosure around the company’s growth options. We also expect buybacks to become significantly more aggressive in the New Year. Furthermore, and most fundamental to our thesis, it provides an opportunity to highlight the incredibly strategic value of the global distribution network the company has built out over 30 years that is virtually unrivaled within the FinTech universe. For instance, Euronet charges companies like Remitly (and other competitors who are thought to be superior with richer valuations) for access to their payment rails. The company’s capital "receiving capability" is nearly 100% globally (touching billions of bank accounts, digital wallets, etc.); a claim few competitors can match. However, unlocking this value may require a strategic pivot—either a sale to a larger fintech player or a take-private transaction. Until management can credibly demonstrate a turnaround or endorses a strategic review, the market may not reward this unique and latent potential. While deserving of increased skepticism, the market has overly punished shares and the stock is currently the cheapest it has ever been by a wide margin, and it is even at a 20%+ discount to where inferior, negative growth Intermex was acquired mere months ago.

BSD Analysis:
Euronet Worldwide is a deeply undervalued global fintech infrastructure play executing a massive transformation from a legacy cash business to a high-growth digital payments platform. The company's formidable moat lies in its highly diversified, three-segment asset base—ATMs, digital content/prepaid, and money transfer—all running on its scalable, proprietary REN network. The critical near-term catalyst is the accelerating adoption of its digital platforms, with transactions growing over 30% year-over-year, and the rapid expansion of its high-margin wholesale cross-border platform, Dandelion. This strategic mix shift, combined with disciplined cost control, is successfully expanding operating margins, which grew by over 100 basis points in the recent quarter. Despite reliable targets for double-digit earnings growth, the stock is trading at an absurdly low 10.1x forward P/E, a steep discount to the industry average. Analysts believe this mispricing creates an asymmetric upside of over 60% as the market is forced to re-rate the company to reflect its true compounding power and profitability. Strategic partnerships with giants like Google and Citigroup further reinforce Euronet's competitive standing, positioning it to dominate the secular growth of the global digital remittance market.

Pitch Summary:
Take for instance, FIVN, whose subscription growth went from 16% in Q2 to 10% in Q3 and the stock has extrapolated the deceleration with minimal terminal cash flows assumed. Our read of the business’s future is more optimistic, and we believe some positive AI proof points are still stacking up in FIVN’s favor. While the "land and expand" AI story is taking longer to materialize in the P&L due to complex implementation cycles, the underlying demand remains robust—Enterprise AI revenue grew over 40% again in the quarter and Enterprise AI bookings grew over 80% y/y. We see the current growth headwinds as minor execution issues rather than sure signs of structural obsolescence. Competition in the CCaaS space is no doubt intense, but FIVN, in our analysis, is currently priced for negative growth indefinitely despite leading the shift to AI-enabled contact centers and acting as a software platform toll road, so to speak, for any AI-point solutions that gain commercial traction. The stock now trades at just 1x 2027 revenue (~1.5x gross profit) and 5x Adjusted EBITDA, a massive discount to software peers trading at ~13x EBITDA, and major discounts to recent and relevant transaction comps such as enterprise competitor Genesys receiving a $15 billion private valuation mark (>5x sales), and the recent acquisition of low-growth, levered Verint by Thoma Bravo at ~3x gross profit. We would also note that activist Anson Funds (who have board representation and information asymmetry) more than doubled their position recently. The current valuation provides a significant margin of uncertainty and is further buttressed by a new $150 million share repurchase program, coupled with call options on the AI cycle and potential renewed M&A interest in a consolidating sector.

BSD Analysis:
Five9 is a high-growth platform that is capitalizing on the massive, structural pivot in the contact center industry toward high-margin cloud solutions. The core investment thesis is validated by the explosive adoption of its Genius AI suite, which is driving accelerating top-line growth by automating high-friction workflows for enterprise clients. Enterprise AI revenue is exploding, growing over 40% year-over-year and now included in virtually all new deals exceeding $1 million in Annual Recurring Revenue (ARR), proving its mission-critical utility. This strategic mix shift is fueling significant margin expansion, with Adjusted EBITDA margins hitting a record 25% and targeting the demanding "Rule of 40+" metric by 2027. Despite competing fiercely against scale players like NICE and Genesys, Five9's focus on a unified, AI-enabled platform and high customer retention keeps its moat robust. The company's valuation, though a premium to market, is fundamentally underpinned by a massive and expanding Total Addressable Market (TAM), which extends to displacing human labor with automation. Sustained execution on its AI roadmap and continued enterprise wins should drive a significant, profitable re-rating, with non-GAAP EPS projected to approach $3.00 for the current fiscal year.

Pitch Summary:
CSW Industrials, Inc. is positioned as a quality industrial growth company with a disciplined M&A strategy, focusing on expanding its Contractor Solutions segment, particularly the RectorSeal brand. The company has a history of strategic acquisitions, such as MARS Parts and Aspen Manufacturing, to enhance its HVAC/R repair market presence. Despite a recent stock price decline, CSW's valuation is now more reasonable, offering potential upside as the industry recovers.

BSD Analysis:
CSW Industrials has evolved from a collection of industrial brands into a focused industrial compounder with strong cash flow and a strategic emphasis on the plumbing and HVAC/R markets. The company's recent acquisitions, MARS Parts and Aspen Manufacturing, are expected to bolster its market position in the HVAC/R repair sector, which benefits from long-term industry tailwinds. While the company faces competition from private equity in acquiring niche brands, its established distribution channels and brand recognition provide a competitive edge. The management's capital allocation strategy, focusing on organic growth, accretive acquisitions, and shareholder returns, has been effective, and the company's high free cash flow conversion supports future growth initiatives. Although the stock is not considered cheap, its quality and growth potential make it an attractive investment, especially if the price falls below $230 per share.

Pitch Summary:
Luks Group is trading significantly below its asset value, with net cash and investment properties exceeding its market price. The company has a history of share buybacks and a stable dividend payout ratio, suggesting potential for shareholder returns.

BSD Analysis:
Luks Group's stock is undervalued, trading at a fraction of its asset value, which includes significant net cash and investment properties. The company's management, led by the founding family, has maintained a rational development strategy and a consistent dividend payout ratio. While the cement business in Vietnam faces challenges due to oversupply, the company's investments in property and hotel operations offer diversification and potential growth. The substantial family ownership allows for significant buyback potential, which could support the stock price. However, investors should be cautious of the pressures in the cement sector and the overall market conditions in Vietnam.

Pitch Summary:
UroGen Pharma is positioned to capitalize on its proprietary RTGel technology with its newly approved drug Zusduri, targeting a large market for non-muscle invasive bladder cancer. The company has a proven track record with its previous drug Jelmyto, and analysts project significant revenue growth, supporting a strong buy recommendation.

BSD Analysis:
UroGen's RTGel technology allows for targeted delivery of chemotherapy drugs, minimizing the need for invasive surgeries. With the FDA approval of Zusduri, UroGen is set to address a $5 billion market, with expectations of $1 billion in peak revenue. The company's market capitalization is projected to grow significantly, supported by strong sales forecasts for both Zusduri and Jelmyto. Despite risks of generic competition, UroGen has successfully defended its patents, ensuring market exclusivity until 2031. The company's financial position is stable, with sufficient cash reserves to reach profitability, although there is a risk of needing additional capital.

Pitch Summary:
Despite recent setbacks in Alzheimer's trials, Novo Nordisk remains a strong investment due to its robust pipeline, market leadership in diabetes care, and undervalued stock price.

BSD Analysis:
Novo Nordisk's recent failure in Alzheimer's trials was anticipated, and the company is not reliant on these results for its success. The company's core business in diabetes and obesity treatments continues to perform well, with promising developments in other therapeutic areas such as chronic kidney disease and cardiovascular risk. The stock's current low valuation, combined with its strong revenue growth and potential new product launches, presents a compelling investment opportunity. The market's reaction to the trial results appears to be driven more by sentiment than fundamentals, suggesting potential for a rebound as sentiment improves. Novo Nordisk's dividend yield also provides an attractive income stream for investors.

Pitch Summary:
Analog Devices, Inc. is positioned to benefit from technological advancements in electric vehicles and low earth orbiting satellites. The company has consistently delivered strong financial performance and shareholder returns through dividends and stock buybacks. Its strategic acquisitions and expansion into subsystem solutions enhance its growth prospects.

BSD Analysis:
Analog Devices has demonstrated resilience and adaptability in the face of market challenges, such as tariff impacts and potential AI market fluctuations. The company's robust cash flow and financial management allow it to maintain a strong position in the semiconductor industry. Its focus on emerging technologies and infrastructure electrification positions it well for future growth. Despite geopolitical risks, ADI's diversified industry presence and strategic initiatives provide a solid foundation for continued success.

Pitch Summary:
QQQI is a high-income ETF that has consistently delivered yields exceeding 10% since its inception. It employs a unique strategy by writing covered calls and using a portion of the premiums to purchase out-of-the-money call options, allowing for some upside potential. This strategy has resulted in a total return of 30.9% since inception, outperforming many peers.

BSD Analysis:
QQQI's strategy of combining covered calls with call spreads allows it to generate substantial income while retaining some upside potential, making it attractive in a low-risk-free rate environment. The ETF has paid 21 consecutive distributions, averaging $0.61 per share, and has a 14.03% yield based on the current share price. In 2025, it generated a 12.6% yield on its share price, outperforming the S&P 500's 12.45% return. With big tech trading at low valuations, QQQI is well-positioned for growth, especially as risk-free assets decline. The ETF's top holdings are undervalued compared to traditional consumer staples, suggesting further potential for appreciation.

Pitch Summary:
Meta Platforms is a buy due to its strong ad business performance, AI-driven growth, and recent valuation dip. Despite rising CAPEX and regulatory risks, the company's investments in AI are yielding immediate benefits, positioning it for future growth.

BSD Analysis:
Meta's Q3 earnings report showed significant revenue and user base growth, driven by its ad business and AI advancements. The company's AI-powered ad tools are enhancing targeting capabilities, supporting pricing power, and extending its growth runway. Despite concerns over high CAPEX and regulatory challenges, Meta's investments in AI infrastructure are expected to deliver real-time benefits, unlike previous speculative ventures. The market's current EPS growth expectations may be conservative, as Meta's monetization strategies are likely to yield long-term gains. The stock's recent sell-off presents a buying opportunity, with a potential upside of over 24% in the next year.

Pitch Summary:
W. P. Carey Inc. has successfully transformed its business model by spinning off weaker assets, reducing debt, and focusing on industrial properties with strong leases. This strategic shift has improved its growth prospects and valuation, positioning it for long-term success.

BSD Analysis:
W. P. Carey Inc. stands out in the net lease REIT sector due to its longer average lease terms, CPI-based rent escalations, and focus on industrial properties. The company's ability to secure off-market deals and its leadership in the European market provide a competitive edge. Despite a recent dividend cut, the company's strategic transformation has led to improved growth potential and a stronger financial position. With a current AFFO multiple of 13.3x and a dividend yield of 5.4%, W. P. Carey is well-positioned to deliver attractive returns. The company's focus on industrial properties aligns with the growing demand driven by e-commerce and onshoring trends.

Pitch Summary:
Philip Morris International remains a sound 'Buy' due to its strong fundamentals, high profitability, and attractive valuation. Despite a higher share price, the company's robust growth in smoke-free products and pricing power in combustibles make it a compelling investment for potentially strong total returns.

BSD Analysis:
Philip Morris International has demonstrated impressive growth in its smoke-free portfolio, with significant increases in products like IQOS, ZYN, and VEEV. The company's high margins are supported by pricing power and the inelasticity of its products. Despite trading above its historical P/E, the valuation is justified by accelerated revenue and earnings growth. The company's strong balance sheet, with an A- credit rating and a safe net debt-to-EBITDA ratio, further supports its investment case. Risks include potential regulatory changes and higher excise taxes, but the company's market leadership and growth prospects in smoke-free products provide a solid foundation for future performance.

Pitch Summary:
BQE Water is strategically positioned to transition from a period of exceptional one-off income to a sustainable growth trajectory, driven by the commissioning of a new SART plant in China, which secures a long-term revenue stream.

BSD Analysis:
The company's ability to compensate for the loss of non-recurring revenue from previous projects with new recurring revenue from the SART plant for Shandong Gold is crucial. The positive management outlook and strong momentum in technical services suggest that BQE Water can exceed forecasts. However, risks such as dependence on large customers and commodity price fluctuations remain. The company's asset-light business model allows for scalability and operational leverage, supporting accelerated EBITDA growth as new revenue streams are added.